ION 2 (IACB) Shareholders Approve Innovid Deal
by Marlena Haddad on 2021-11-30 at 6:27am

ION Acquisition Corp 2 Ltd. (NYSE:IACB) secured shareholder approval of its combination with ad delivery platform Innovid in a special meeting yesterday.

The combination was approved by 97.4% of participating shares, but it also saw 19,585,174 shares redeemed, removing about 77.4% of the value of its trust, estimated at $253 million heading into the vote.

The deal will still bring $251 million in proceeds to Innovid after redemptions and expenses, which narrowly clears the bar of its $250 million minimum cash condition. But, the transaction was likely not at risk of missing this threshold as ION 2 added $50 million to the PIPE in late October to support the transaction and its sponsor has said it would purchase additional shares if need be towards close.

ION 2 now expects to close the deal later today and the combined company’s ordinary shares and warrants are set to begin trading on the NYSE beginning on Wednesday, December 1 under the ticker symbols “CTV” and “CTV.WS” respectively.

ION 2 initially announced its $1.1 billion deal with Innovid in June. New York-based Innovid is an omnichannel advertising and analytics platform placing video marketing on streaming and social media services.

Innovid is set to be the second ad company that started up in Israel that the ION team has taken to public markets this year having announced a deal with Taboola (NASDAQ:TBLA) in January. TBLA closed yesterday at $8.15.


  • Evercore LLC acted as sole financial and capital markets advisor to Innovid and also acted as a placement agent on the PIPE.
  • Latham & Watkins LLP and FWMK Law Offices acted as legal counsel to Innovid.
  • Morgan Stanley acted as sole financial advisor to ION and also acted as lead placement agent to ION on the PIPE.
  • White & Case LLP and Goldfarb Seligman & Co. acted as legal counsel to ION.
  • Debevoise & Plimpton LLP acted as legal counsel to the placement agents.
  • Kost Forer, Gabbay & Kasierer, a member of Ernst & Young Global Limited, is acting as independent auditor.
Recent Posts
by Nicholas Alan Clayton on 2024-02-26 at 1:45pm

News and Rumors PR: Medtech firm Agiliti (NYSE:AGTI) has agreed to be acquired by an affiliate of private equity firm Thomas H. Lee Partners (THL) at $10 per share and an enterprise value of $2.5 billion. This represents a 43% premium over the company’s 90-day VWAP and returns it to 100% ownership by THL five...

by Nicholas Alan Clayton on 2024-02-26 at 7:42am

At the SPAC of Dawn The last week of February is to host a moderate amount of SPAC votes and also the potential for some market-moving data releases. Shareholders for five SPACs are to consider extensions this week and seven more SPACs have scheduled completion votes. But, among the more interesting events on the agenda...

by Kristi Marvin on 2024-02-24 at 11:45am

Terms Tracker for the Week Ending February 23, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. As expected, new issuance filings were quiet this week.  But, deal announcements were surprisingly active.  Four more SPACs announced combinations in a shortened holiday week...

by Nicholas Alan Clayton on 2024-02-23 at 2:26pm

Pyrophyte (NYSE:PHYT) faced a major regulatory setback for its combination with mining firm Sio Silica this week, but a recent analogous SPAC deal could provide some encouragement for a path forward. Sio Silica is working to develop a high-grade silica mine in the Vivian Sands outside Winnipeg, Canada and it inked the $708 million combination...

by Nicholas Alan Clayton on 2024-02-23 at 1:37pm

News and Rumors JD Supra: Securities class action lawsuits against SPACs and de-SPACs increased only slightly in 2023 with 27 after 2022 saw 24 and 2021 – 33. Lawsuits concerning the de-SPACing process itself dropped precipitously, however, representing just 21% of cases as compared to 69% in the previous two years and 80% in 2020....


Copyright © 2023 SPACInsider, Inc. All Rights Reserved